Sirolimus Eluting Coronary Stent System

본문 바로가기


Home > Product > Sirolimus Eluting Coronary Stent System
Product
Sirolimus Eluting Coronary Stent System
Posting date : May 14, 2012
Membership
Free Member Scince Nov 30, 2009
Keyword :
Category
Contact
          0 likes     
Product Detail
Company Info
 
Quick Detail
Place of Origin
HS-CODE
S12-
Package & Delivery Lead Time
Detailed Description
Biodegradable Polymer Coating Proven Safety and Efficacy Profile. This DES uses a biodegradable polymer coating on the stainless steel stent platform. The proprietary, top-quality coating process allows the integrity of coated polymer after excessive stent expansion and a systemic elution of sirolimus in a well -controlled fashion after the stent implantation. The safety and efficacy of the product is well documented from a related randomized trial in Europe in CTO patients showing low re-stenosis rate and very promising late loss data. Specifications: Stent Plaform: 316L Stainless Steel Coating Material:PLGA (Biodegradable) Coating Thickness: 4.0±1.0μm Drug: Sirolimus (Rapamycine) Drug Content: 170μg/cm2±20μg/cm2(12mm,18mm) 150μg/cm2±20μg/cm2 (23mm,28mm,33mm) Degradation Time: < 2Months

ECROBOT CO., Ltd, Business Registration Number : 220-88-71747, CEO J.W.Park, TEL : +82-2-552-7676, E-mail : E-mail : Contact us
Address : (Hwanghwa B/D 11F, Yeoksam-dong)320, Gangnam-daero, Gangnam-gu, Seoul, South Korea
About Us Privacy Policy Terms of use Copyright © 2000-2024 ECROBOT.COM. All rights reserved.
Top